11/27
02:47 pm
edsa
Edesa Biotech (NASDAQ:EDSA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Edesa Biotech (NASDAQ:EDSA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/3
11:03 am
edsa
Edesa Biotech (NASDAQ:EDSA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Low
Report
Edesa Biotech (NASDAQ:EDSA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
10/31
05:28 pm
edsa
Edesa Biotech Announces Upcoming Conference Schedule [Canadian Business Journal (Canada)]
Medium
Report
Edesa Biotech Announces Upcoming Conference Schedule [Canadian Business Journal (Canada)]
10/31
04:30 pm
edsa
Edesa Biotech Announces Upcoming Conference Schedule
Low
Report
Edesa Biotech Announces Upcoming Conference Schedule
10/28
07:45 am
edsa
Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study
High
Report
Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study
10/24
12:21 pm
edsa
Edesa Biotech (NASDAQ:EDSA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Edesa Biotech (NASDAQ:EDSA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/8
12:20 pm
edsa
Edesa Biotech (NASDAQ:EDSA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Edesa Biotech (NASDAQ:EDSA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.